Ibrutinib - CaLiGraph

CaLiGraph

Property	Value
rdf:type	World Health Organization essential medicine owl:NamedIndividual Orphan drug Piperidine Johnson & Johnson brand Acrylamide Pyrazolopyrimidine AbbVie brand Phenol ether Tyrosine kinase inhibitor Drug granted breakthrough therapy designation
rdfs:label	Ibrutinib
owl:sameAs	dbr:Ibrutinib
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Johnson_&_Johnson_brands http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/Category:World_Health_Organization_essential_medicines http://en.wikipedia.org/wiki/WHO_Model_List_of_Essential_Medicines http://en.wikipedia.org/wiki/Protein_kinase_inhibitor http://en.wikipedia.org/wiki/Category:Piperidines http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Pyrazolopyrimidines http://en.wikipedia.org/wiki/Category:Acrylamides http://en.wikipedia.org/wiki/Category:AbbVie_brands http://en.wikipedia.org/wiki/Category:Tyrosine_kinase_inhibitors http://en.wikipedia.org/wiki/Category:Phenol_ethers http://en.wikipedia.org/wiki/Bruton's_tyrosine_kinase
skos:prefLabel	Ibrutinib
skos:altLabel	IMBRUVICA Ibrutix Imbruvica Imbruvica (ibrutinib) ibrutinib
clgo:alternativeName	Imbruvica, others
clgo:casNumber	936563-96-1
clgo:chEBI	76612
clgo:chEMBL	1873475
clgo:drugbank	DB09053
clgo:fdaUniiCode	1X70OSD4VX
clgo:kegg	D10223
clgo:medlinePlus	a614007
clgo:pubchem	24821094
is clgo:product of	AbbVie Beacon Pharmaceuticals

About: clgr:Ibrutinib